Peritoneal dialysis in children with end-stage renal disease

被引:29
|
作者
Schaefer, Franz [1 ]
Warady, Bradley A. [2 ]
机构
[1] Ctr Pediat & Adolescent Med, Div Pediat Nephrol, D-69120 Heidelberg, Germany
[2] Childrens Mercy Hosp & Clin, Sect Pediat Nephrol, Kansas City, MO 64108 USA
关键词
LEFT-VENTRICULAR HYPERTROPHY; GROWTH-HORMONE TREATMENT; LONG-TERM DIALYSIS; PEDIATRIC-PATIENTS; INFECTIONS RECOMMENDATIONS; PARATHYROID-HORMONE; YOUNG-ADULTS; EXPERIENCE; GUIDELINES; INFANTS;
D O I
10.1038/nrneph.2011.135
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Peritoneal dialysis is the preferred chronic dialysis modality for most children owing to its almost universal applicability and superior compatibility with lifestyle over other modalities. Although technological advances and increasing clinical experience have impacted favorably on patient and technique survival, clinical research in pediatric peritoneal dialysis has been hampered by the low incidence of end-stage renal disease (ESRD) in the pediatric population. To overcome this limitation, several international registries have emerged in the past few years to complement other long-standing registries, which together have provided useful information regarding technique-specific complications and comorbidities associated with ESRD in children undergoing chronic peritoneal dialysis. In this Review, we summarize the most relevant findings from these studies, highlighting the substantial variation in patient conditions, peritoneal dialysis practices and management of comorbidities encountered in different parts of the world.
引用
收藏
页码:659 / 668
页数:10
相关论文
共 50 条
  • [41] Risk factors for loss of residual renal function in children with end-stage renal disease undergoing automatic peritoneal dialysis
    Shen, Qian
    Fang, XiaoYan
    Zhai, YiHui
    Rao, Jia
    Chen, Jing
    Miao, QianFan
    Gong, YiNv
    Yu, MingHui
    Zhou, Qing
    Xu, Hong
    PERITONEAL DIALYSIS INTERNATIONAL, 2020, 40 (04): : 368 - 376
  • [43] HYPERTROPHIC CARDIOMYOPATHY IN CHILDREN WITH END-STAGE RENAL-DISEASE (DIALYSIS)
    GLASER, J
    URBACH, J
    DRUKKER, A
    INTERNATIONAL JOURNAL OF PEDIATRIC NEPHROLOGY, 1981, 2 (01): : 63 - 64
  • [44] Calcification of end-stage renal allograft in a peritoneal dialysis patient
    Sue, YM
    Wang, CC
    Huang, JJ
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (08) : 2151 - 2152
  • [45] Chronic renal failure, end-stage renal disease, and peritoneal dialysis in Gitelman's syndrome
    Bonfante, L
    Davis, PA
    Spinello, M
    Antonello, A
    D'Angelo, A
    Semplicini, A
    Calò, L
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (01) : 165 - 168
  • [46] Peritoneal dialysis for the treatment or end-stage renal failure.
    Siohan, P
    Khayat, R
    Michel, C
    Mignon, F
    SEMAINE DES HOPITAUX, 1996, 72 (7-8): : 222 - 225
  • [47] Automated Peritoneal Dialysis is Suitable for Polycystic Kidney Disease Patients with End-Stage Renal Disease
    Li, Xiao
    Ren, Hong
    Xie, Jingyuan
    Huang, Xiao-Min
    Zhang, Chun-Yan
    Chen, Nan
    CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 2015, 5 (02): : 140 - 144
  • [48] Peritoneal dialysis for patients with diabetes and end-stage renal disease - Sorting out the biases?
    Finkelstein, FO
    Smith, JD
    ASAIO JOURNAL, 1996, 42 (01) : 1 - 3
  • [49] Hyperleptinemia in patients with end-stage renal disease undergoing continuous ambulatory peritoneal dialysis
    Dagogo-Jack, S
    Ovalle, F
    Landt, M
    Gearing, B
    Coyne, DW
    PERITONEAL DIALYSIS INTERNATIONAL, 1998, 18 (01): : 34 - 40
  • [50] Nitric oxide production is low in end-stage renal disease patients on peritoneal dialysis
    Schmidt, RJ
    Yokota, S
    Tracy, TS
    Sorkin, MI
    Baylis, C
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1999, 276 (05) : F794 - F797